Gland Pharma Limited (NSE:GLAND)
1,749.10
-24.90 (-1.40%)
Nov 28, 2025, 10:40 AM IST
Gland Pharma Revenue
Gland Pharma had revenue of 14.87B INR in the quarter ending September 30, 2025, with 5.76% growth. This brings the company's revenue in the last twelve months to 58.01B, down -1.51% year-over-year. In the fiscal year ending March 31, 2025, Gland Pharma had annual revenue of 56.17B, down -0.85%.
Revenue (ttm)
58.01B
Revenue Growth
-1.51%
P/S Ratio
5.04
Revenue / Employee
13.33M
Employees
4,351
Market Cap
292.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 56.17B | -482.18M | -0.85% |
| Mar 31, 2024 | 56.65B | 20.40B | 56.29% |
| Mar 31, 2023 | 36.25B | -7.76B | -17.64% |
| Mar 31, 2022 | 44.01B | 9.38B | 27.08% |
| Mar 31, 2021 | 34.63B | 8.30B | 31.51% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Gland Pharma News
- 24 days ago - Nomura cautious on Gland Pharma, trims estimates post Q2 miss but sees long-term visibility - Business Upturn
- 24 days ago - Gland Pharma Ltd (NSE:GLAND) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 24 days ago - Q2 2026 Gland Pharma Ltd Earnings Call Transcript - GuruFocus
- 24 days ago - Gland Pharma Q2 Results: Revenue jumps 5.8% YoY to Rs 1,487 crore, net profit up 12.2% - Business Upturn
- 27 days ago - Gland Pharma Ltd (NSE:GLAND) Q2 2026 Earnings Report Preview: What To Expect - GuruFocus
- 2 months ago - These Indian pharma stocks tumble as Trump announces 100% tariff on branded drugs - Business Upturn
- 2 months ago - Gland Pharma shares fall over 4% as Trump announces 100% tariff on pharma imports - Business Upturn
- 2 months ago - Gland Pharma down 4%, Sun Pharma slips 2.6%, Dr Reddy’s down 2%, Zydus nearly 3%, Aurobindo down 2% as Trump’s 100% pharma tariff jolts sector - Business Upturn